The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Gammagard S/DHuman Normal Immunoglobulin for Intravenous Administration Powder and solvent for solution for infusion



Baxalta Innovations GmbHPA2004/003/001

Main Information

Trade NameGammagard S/DHuman Normal Immunoglobulin for Intravenous Administration Powder and solvent for solution for infusion
Active SubstancesHUMAN PLASMA PROTEIN >90% GAMMA GLOBULIN
Dosage FormPowder and solvent for solution for infusion
Licence HolderBaxalta Innovations GmbH
Licence NumberPA2004/003/001

Group Information

ATC CodeJ06BA Immunoglobulins, normal human
J06BA02 immunoglobulins, normal human, for intravascular adm.

Status

License statusAuthorised
Licence Issued01/05/1998
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back